5 Essential Tips for Choosing Pharma Advisors
                     5 Essential Tips for Choosing Pharma
Advisors
A practical guide for biotech and pharma founders, program leads, and regulatory and commercial heads
Few industries combine scientific complexity, regulatory scrutiny, and commercial risk the way
pharma does. Whether you're a start-up preparing for a first IND or an established company entering
a new market, an outside advisor can save you months of work and help you avoid costly missteps.
The wrong one can do the opposite: burn budget, slow decisions, and create compliance exposure.
At XFDA Pharma Advisors, we see these patterns every day. This guide gives you five tips for
choosing an advisor who adds real value, plus a scorecard, a list of questions for your first call, and
answers to common questions.
5 Essential Tips for Choosing Pharma Advisors Page 1
Why the Choice of Advisor Matters
Pharma programs are long, capital-intensive, and heavily regulated. A decision made early, such as
the choice of regulatory pathway, the design of a pivotal study, or the market sequence for a launch,
can shape outcomes for years. Advisors are often brought in precisely at these decision points, which
means their judgment carries real weight.
Advisors typically support work in areas such as these:
Area Typical support
Regulatory strategy and support Pathway selection, agency interactions, dossier planning and review
GMP and quality compliance Quality systems, audit readiness, gap assessments, corrective action
plans
Product development support Development planning, CMC strategy, clinical and non-clinical planning
Global market access Market entry sequencing, regional requirements, pricing and
reimbursement context
Expert consulting Independent review, second opinions, specialist input on specific
questions
1. Match Expertise to Your Specific Stage and Need
"Pharma expert" is not a single skill set. An advisor who excels at late-stage clinical strategy may
have little to offer on preclinical positioning, market access, or CMC (chemistry, manufacturing, and
controls).
Before you start searching, define the problem:
• Are you shaping a regulatory pathway, designing a trial, or preparing for licensing talks?
• Is your challenge scientific, commercial, or operational?
• What will success look like in six to twelve months?
With a clear scope, you can ask candidates how they would approach your problem. Strong advisors
will push back, refine the question, and show they understand the nuance. Generalists tend to offer
generic frameworks.
Tip: write a one-page brief covering your product, stage, target markets, timeline, and the specific decision you
need help with. Candidates who respond to the brief with sharp questions are usually the ones worth speaking
to again.
5 Essential Tips for Choosing Pharma Advisors Page 2
2. Verify a Track Record, Not Just a Résumé
Titles and past employers matter less than outcomes. Ask for specifics:
• Which programs or products did they directly influence, and what was their role?
• What decisions were theirs, and what did the results look like?
• Have they worked on challenges similar to yours, including ones that didn't go well?
Reference calls help here. Speak with former clients or colleagues and ask what the advisor did that
others wouldn't have. An advisor who can discuss setbacks candidly, and what they learned, is often
more valuable than one with a spotless story.
Questions for reference calls
• What problem did the advisor help you solve, and how did you measure the result?
• How did they handle disagreement or bad news?
• Were deliverables on time and within the agreed scope?
• Would you hire them again for a similar need?
3. Check Regulatory and Market Depth Across Regions
Pharma regulation and reimbursement vary widely by geography. Approaches that work with the FDA
may not translate to the EMA, India's CDSCO, or other authorities. Pricing, access, and payer
dynamics differ too.
If you plan to operate in multiple regions, ask:
• Which authorities and markets has the advisor worked with firsthand?
• Do they maintain current relationships and knowledge, given how quickly guidance and policy
change?
• Can they bring in specialists for areas outside their own expertise?
Honesty about limits is a good sign. Advisors who claim expertise everywhere deserve extra scrutiny.
5 Essential Tips for Choosing Pharma Advisors Page 3
4. Assess Independence, Conflicts of Interest, and Compliance
Pharma advisors often hold relationships with investors, competitors, or vendors. That isn't
automatically a problem, but it needs to be transparent.
Ask directly:
• Do they have financial interests in companies, products, or service providers they might
recommend?
• Are they working with competitors in your space?
• How do they handle confidentiality and information barriers?
Also confirm that they follow applicable industry codes and anti-corruption laws, particularly when
engagement involves healthcare professionals, payers, or government bodies. A clear written
agreement covering confidentiality, IP ownership, and conflict disclosure protects both sides.
What a good engagement agreement covers
• Scope of work, deliverables, and timelines
• Fees, expenses, and how changes to scope are handled
• Confidentiality and data-handling terms
• Ownership of work product and intellectual property
• Conflict-of-interest disclosure and compliance obligations
• Termination terms
5. Evaluate Communication Style and Working Fit
Technical brilliance doesn't help if an advisor can't translate it into decisions your team can act on.
During early conversations, notice whether they:
• Explain complex issues clearly, without hiding behind jargon
• Listen and ask good questions before offering opinions
• Give direct recommendations along with the reasoning and trade-offs
• Respect your team's expertise and constraints
Consider a short paid pilot, such as a gap analysis or strategy review, before committing to a long
engagement. It shows how they work in practice and gives you a concrete deliverable to judge.
5 Essential Tips for Choosing Pharma Advisors Page 4
Red Flags to Watch For
• Guaranteed outcomes (approvals, valuations, timelines)
• Vague deliverables or unclear pricing
• Reluctance to provide references
• Pressure to sign quickly
• Name-dropping in place of substance
Strong Advisor vs. Weak Advisor
Area Strong advisor Weak advisor
Scoping Refines your question and pushes back Offers a generic framework for every client
where needed
Track record Explains their role, decisions, and lessons Lists titles and employers only
learned
Regional depth Names the authorities and markets they Claims expertise everywhere
know firsthand
Transparency Discloses conflicts and works under a clear Avoids questions about other clients or
agreement interests
Communication Gives clear recommendations with Hides behind jargon or hedges every
trade-offs answer
Pricing Clear deliverables and clear fees Vague scope and open-ended billing
Advisor Scorecard
Rate each candidate from 1 (weak) to 5 (strong) on the criteria below, then compare totals. Weight
the criteria that matter most for your stage.
Criteria Candidate A Candidate B Candidate C
Expertise matches our stage and need
Verified track record and references
Regional regulatory and market depth
Independence and compliance
Communication and working fit
Total (out of 25)
5 Essential Tips for Choosing Pharma Advisors Page 5
Questions to Ask on Your First Call
• How would you approach the problem described in our brief?
• Which similar projects have you worked on, and what was your exact role?
• Which regulators and markets do you know firsthand?
• Who else would work on our project, and what would you handle personally?
• Do you have any conflicts of interest we should know about?
• How do you report progress, and how often?
• What would you need from our team to be effective?
• What does a small initial engagement look like?
Frequently Asked Questions
How long should the selection process take?
For a focused need, a few weeks is usually enough: a written brief, two or three conversations,
reference calls, and a short pilot if the engagement will be large.
Should I choose an individual consultant or a firm?
It depends on the scope. An individual can be ideal for a narrow, senior-level question. A firm may
suit work that spans several disciplines or regions, as long as you know who will actually do the work.
Is a pilot project worth the cost?
Often yes. A small, well-defined engagement shows you how the advisor works and gives you a
deliverable to judge before you commit to a larger budget.
What should I do if I am unsure about a candidate?
Treat it as a signal. Ask for more references, narrow the scope, or compare against another
candidate using the scorecard.
Conclusion
Choosing a pharma advisor is a strategic decision, not a procurement exercise. Define your need,
verify real-world results, confirm regional depth, insist on transparency, and test the working
relationship. Done well, the right advisor becomes an extension of your team and a multiplier for your
program.
Looking for guidance on your next pharma milestone? Contact our team for a consultation.
5 Essential Tips for Choosing Pharma Advisors Page 6